News

Feature Story

The PATH Malaria Vaccine Initiative announces collaboration to develop Plasmodium vivax vaccine

Researchers announced a collaboration to develop a new malaria vaccine approach targeted at Plasmodium vivax, the most widely distributed malaria parasite. The PATH Malaria Vaccine Initiative will collaborate with United States Army malaria researchers and GlaxoSmithKline Biologicals to accelerate the development of a P. vivax malaria vaccine which, unlike the P. falciparum parasite, has difficult challenges to overcome, such as a persistent liver stage and questionable drug treatment efficacy in primaquine, the only drug available for radical cure of P. vivax. This collaboration and continued research to understand the P. vivax parasite will make a huge impact in progress towards elimination.

Read the PATH Malaria Vaccine Initiative announcement >

Feature Story archive >

In the News

As momentum for malaria elimination increases, the most up-to-date information and news regarding elimination initiatives and events around the globe will be posted here.

Read more >

Job Vacancies

The MEG introduces a resource for those seeking employment and for those seeking to fill positions in the field of malaria. Employment opportunities from various organizations working in malaria will be posted here. Check back regularly for the latest updates. Additionally, if you would like MEG to post an opportunity, please Contact Us.

Read more >

Contributing to this Website

If you have information to contribute to this malaria elimination resource website, or if you have suggestions on how to improve it, please Contact Us.